RMTI
Closed
Rockwell Medical Inc
0.831
-0.017 (-2.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.848
Day's Range: 0.8 - 0.842
Send
sign up or login to leave a comment!
When Written:
1.98
Rockwell Medical Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for the treatment of iron deficiency and other diseases. The company's lead product is Triferic, a therapy for the treatment of iron deficiency in hemodialysis patients. Triferic is a unique iron compound that is delivered directly to the patient's bloodstream during dialysis, providing a more effective and efficient method of iron delivery than traditional oral or intravenous iron therapies.
Rockwell Medical was founded in 1995 and is headquartered in Wixom, Michigan. The company has a strong research and development program, with a focus on developing new therapies for the treatment of iron deficiency and other diseases. In addition to Triferic, Rockwell Medical has a number of other products in development, including therapies for the treatment of anemia and chronic kidney disease.
Rockwell Medical is publicly traded on the NASDAQ stock exchange under the ticker symbol RMTI. The company has a market capitalization of approximately $300 million as of August 2021.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Rockwell Medical was founded in 1995 and is headquartered in Wixom, Michigan. The company has a strong research and development program, with a focus on developing new therapies for the treatment of iron deficiency and other diseases. In addition to Triferic, Rockwell Medical has a number of other products in development, including therapies for the treatment of anemia and chronic kidney disease.
Rockwell Medical is publicly traded on the NASDAQ stock exchange under the ticker symbol RMTI. The company has a market capitalization of approximately $300 million as of August 2021.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








